Notably, METTL3 functions as An oncogenic driver in bladder cancer by engaging in a functional interaction with DiGeorge syndrome critical region gene 8 (DGCR8), thereby enhancing the biogenesis of miR-221/222 through positive regulation of pri-miR221/222 processing [58]. Here, METTL3 is linked to urinary bladder carcinoma.